Since Johan Christophorous first described nailfold capillaroscopy in 1663 and Giovanni Rasori and Maurice Raynaud studied capillary changes in inflammation and ischemia in the 18th and 19th centuries, 1 interest in the microcirculation has grown significantly.Advances in imaging technologies over the past several decades have enabled clinicians and researchers to visualize and interrogate the microcirculation directly, or measure parameters, traces or indices that reflect the structural and functional status of the microcirculation. Several of these imaging technologies provide quantitative "readouts" that may directly or indirectly be employed as biomarkers. 2,3 Such noninvasive, imaging biomarkers have the potential to improve clinical assessment of the microcirculation and disease diagnosis, and enable long-term monitoring of treatment response. 4